Friday, August 29, 2025
African research, science and scholarly  news
HomeRESEARCH PAPERSReal-World Outcomes of Oral Short-Course Regimen for Rifampicin-Resistant Tuberculosis in High HIV...

Real-World Outcomes of Oral Short-Course Regimen for Rifampicin-Resistant Tuberculosis in High HIV Settings: Insights from South Africa

Why a Promising TB Treatment Is Falling Short in High HIV Settings 🚨🧬



Illustrative Image: Real-World Outcomes of Oral Short-Course Regimen for Rifampicin-Resistant Tuberculosis in High HIV Settings: Insights from South Africa
Image Source & Credit: WHO
Ownership and Usage Policy

A recent study by Stadler et al. (2025) titled “Treatment outcomes with an oral short course regimen for rifampicin-resistant tuberculosis in a high HIV prevalence, programmatic setting in South Africa” published in Clinical Infectious Diseases revealed that although the oral SCR has shown promise in controlled trials, its effectiveness was limited in this high-burden, programmatic setting.

Despite rapid culture conversion, oral short-course regimens showed limited success in high HIV, resource-limited settings.– Stadler et al. 2025

The study titled “Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa” examines the effectiveness of a fully oral, 7-drug short-course regimen (SCR) that includes bedaquiline and linezolid for treating rifampicin-resistant tuberculosis (RR-TB). Conducted in the Eastern Cape Province—an area with both a high TB burden and significant HIV co-infection rates—the research evaluates real-world treatment performance beyond clinical trials. Key objectives included assessing clinical and bacteriological outcomes, measuring treatment success according to WHO definitions, analyzing TB-free survival at 18 months, monitoring time to sputum culture conversion, and identifying predictors of poor outcomes, particularly in relation to HIV status. Findings revealed that although the oral SCR has shown promise in controlled trials, its effectiveness was limited in this high-burden, programmatic setting. Challenges such as delayed drug resistance testing, restricted access to diagnostic imaging, and overall implementation barriers contributed to underperformance. The study highlights the need for stronger support systems, improved risk stratification, and enhanced patient follow-up to optimize outcomes for RR-TB patients in similar contexts.

How the Study was Conducted

The study was a retrospective cohort analysis conducted in a real-world, programmatic setting in Eastern Cape Province, South Africa—an area with high rates of rifampicin-resistant tuberculosis (RR-TB) and HIV. Data were collected from four decentralized drug-resistant TB treatment sites, with patients enrolled between July 2018 and February 2020. The study population included adults (≥18 years) with newly diagnosed RR-TB who initiated the oral short-course regimen (SCR). Patients with prior second-line TB treatment or confirmed resistance to fluoroquinolones or bedaquiline were excluded. A total of 248 patients met the eligibility criteria.

All participants were treated with a 7-drug, fully oral regimen consisting of bedaquiline, linezolid, levofloxacin, clofazimine, ethambutol, pyrazinamide, and high-dose isoniazid, administered for approximately 9–11 months. Data were obtained from routine programmatic sources, including clinical records, laboratory results (such as sputum cultures and drug susceptibility tests), and HIV-related information (CD4 counts and ART status). Patients were monitored for 18 months after treatment initiation to evaluate TB-free survival. The primary outcome was TB-free survival at 18 months, while secondary outcomes included WHO-defined treatment outcomes (cure, treatment completion, death, or loss to follow-up), time to sputum culture conversion, and identification of predictors of poor outcomes such as age, HIV status, and laboratory markers. The authors employed Kaplan-Meier survival methods and Cox proportional hazards models to assess survival probabilities and determine risk factors associated with unfavorable outcomes.

What the Authors Found

The authors found that while the oral short-course regimen (SCR) for RR-TB achieved rapid bacteriological response (96.8% culture conversion by 90 days), its overall treatment success was low (37.5%), mainly due to high mortality (21.6%) and loss to follow-up (19.4%) in a real-world, high HIV prevalence setting.

Why is this important

Real-World Effectiveness vs. Clinical Trials: The study highlights a significant gap between the strong outcomes seen in controlled clinical trials and the weaker results observed in resource-limited, high-burden settings. Systemic barriers—such as delayed diagnostics and inadequate patient support—limit the real-world impact of promising regimens.

Public Health Significance: With RR-TB being one of the hardest forms of TB to treat, and South Africa facing high HIV co-infection rates, the findings underscore the urgent need to adapt strategies in regions most affected by dual epidemics.

Clinical Insights: Predictors of poor outcomes (older age, low albumin, high bacterial load) can help clinicians identify high-risk patients. Importantly, rapid bacteriological response does not always guarantee long-term treatment success, challenging current metrics of success.

Policy & Program Implications: The study emphasizes that effective treatment requires more than drugs—it depends on stronger health systems. Key priorities include improving diagnostic capacity, providing robust patient support, and strengthening follow-up mechanisms to reduce mortality and loss to follow-up.

What the Authors Recommended

  • The study advocates improving patient follow-up mechanisms to reduce loss to follow-up and expanding diagnostic infrastructure (drug susceptibility testing, radiology) to enable timely, accurate treatment decisions.
  • The authors ought to use baseline clinical and laboratory markers—such as age, serum albumin, and smear status—to identify high-risk patients and provide tailored monitoring and interventions accordingly.
  • Prioritize early ART initiation and adherence support, especially for patients with advanced HIV or low CD4 counts, to improve treatment outcomes.
  • Furthermore, regularly evaluate regimen performance in programmatic settings, recognizing that early culture conversion does not always equate to long-term success. Broader indicators should be used to measure effectiveness.
  • In addition, modify treatment protocols and support structures to fit the realities of decentralized, resource-limited settings, and ensure new regimens are tested beyond clinical trials before wide-scale implementation.

In conclusion, while the oral short-course regimen demonstrates encouraging bacteriological response, its limited effectiveness in real-world, high HIV prevalence settings underscores the critical importance of strong health systems, timely diagnostics, and tailored patient support. To truly improve outcomes for rifampicin-resistant TB, future strategies must go beyond promising drug regimens and address the structural, clinical, and programmatic barriers that shape patient survival and long-term success.

Cite this Article (APA 7)

Editor, A. M. (August 29, 2025). Real-World Outcomes of Oral Short-Course Regimen for Rifampicin-Resistant Tuberculosis in High HIV Settings: Insights from South Africa. African Researchers Magazine (ISSN: 2714-2787). https://www.africanresearchers.org/real-world-outcomes-of-oral-short-course-regimen-for-rifampicin-resistant-tuberculosis-in-high-hiv-settings-insights-from-south-africa/

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Articles

Recent ART Initiation Linked to Higher Mortality in HIV-Associated Cryptococcal Meningitis: Insights From African Clinical Trials

Recent ART Initiation Linked to Higher Mortality in HIV-Associated Cryptococcal Meningitis: Insights From African Clinical Trials

Illustrative Image: Recent ART Initiation Linked to Higher Mortality in HIV-Associated Cryptococcal Meningitis: Insights From African Clinical Trials Image Source & Credit: Infectious Disease Advisor Ownership...
Cobalt Mining Laws in DRC and Zambia: Challenges, Inequalities, and the Urgent Need for Legal Reforms

Cobalt Mining Laws in DRC and Zambia: Challenges, Inequalities, and the Urgent Need for Legal Reforms

A recent study by Balyaminu, J. A. (2025) titled "The State of Cobalt Mining Laws: Implications for the Future of Democratic Republic of Congo...
Macroeconomic Factors and Copper Value Addition in Zambia: Insights from a 1980–2021 Study on Exports, GDP, and Resource Management

Macroeconomic Factors and Copper Value Addition in Zambia: Insights from a 1980–2021 Study on Exports, GDP, and Resource Management

Illustrative Image: Macroeconomic Factors and Copper Value Addition in Zambia: Insights from a 1980–2021 Study on Exports, GDP, and Resource Management Image Source & Credit:...
Obesity Kuznets Curve in Africa: Economic Growth, Urbanization, Trade, and Gender-Based Health Insights (2000–2020)

Obesity Kuznets Curve in Africa: Economic Growth, Urbanization, Trade, and Gender-Based Health Insights (2000–2020)

Illustrative Image: Obesity Kuznets Curve in Africa: Economic Growth, Urbanization, Trade, and Gender-Based Health Insights (2000–2020) Image Source & Credit: The Independent Ownership and Usage Policy A...
Adolescent Health in Sub-Saharan Africa: Multi-Country Study Reveals Mental, Nutritional, and Safety Challenges with Schools as Key Protectors

Adolescent Health in Sub-Saharan Africa: Multi-Country Study Reveals Mental, Nutritional, and Safety Challenges with Schools as Key Protectors

Illustrative Image: Adolescent Health in Sub-Saharan Africa: Multi-Country Study Reveals Mental, Nutritional, and Safety Challenges with Schools as Key Protectors Image Source & Credit: ©...
Resolving the GERD Dispute: How Worldviews and the Water-Energy-Food Nexus Can Foster Nile Basin Cooperation

Resolving the GERD Dispute: How Worldviews and the Water-Energy-Food Nexus Can Foster Nile Basin Cooperation

Illustrative Image: Resolving the GERD Dispute: How Worldviews and the Water-Energy-Food Nexus Can Foster Nile Basin Cooperation Image Source & Credit: The exchange Africa Ownership and...
Collaborative Practices Among Yoruba Traditional Healers in Epilepsy Treatment: Insights from a 2024 Study in Southwest Nigeria

Collaborative Practices Among Yoruba Traditional Healers in Epilepsy Treatment: Insights from a 2024 Study in Southwest Nigeria

Illustrative Image: Collaborative Practices Among Yoruba Traditional Healers in Epilepsy Treatment: Insights from a 2024 Study in Southwest Nigeria Image Source & Credit: WIPO Ownership and...
Inclusive Education in Tunisia: Bridging the Gap Between Policy and Practice Through Speech Act Theory

Inclusive Education in Tunisia: Bridging the Gap Between Policy and Practice Through Speech Act Theory

Illustrative Image: Inclusive Education in Tunisia: Bridging the Gap Between Policy and Practice Through Speech Act Theory Image Source & Credit: Modern Ghana Ownership and Usage...
Exploring Gender and Racial Trauma in Maya Angelou’s Memoir: A Literary and Cultural Analysis of I Know Why the Caged Bird Sings

Exploring Gender and Racial Trauma in Maya Angelou’s Memoir: A Literary and Cultural Analysis of I Know Why the Caged Bird Sings

A study by Adhikary, R. P. (2020) titled "Gender and racial trauma in Angelou’s I Know Why The Caged Bird Sings," published in AFRREV...

We are hiring !

About The Author

AR Managing Editor
AR Managing Editor
African Researchers Magazine (ISSN: 2714-2787) - your premier source for latest African research, science and scholarly news

Share Your Research Findings

- Advertisment -

Most Popular